Marcus Lemonis — current Executive Chairman of Bed Bath and Beyond, Inc. — has been appointed CEO of the company.

Two of the state’s largest health systems have reported multi-million-dollar operating losses for the last year, but their outlooks on what that means for the future are wildly different. In some ways ...

YOUNGSTOWN — The city-owned Covelli Centre, Youngstown Amphitheatre and Wean Park entertainment complex may end the year with its first operating loss since 2009 despite another strong year for ticket ...

No. 1 Ohio State is trying to win back-to-back national championships for the first time in school history. The Buckeyes suffered their first loss in the Big Ten championship game against No. 2 ...

Ohio State’s loss at Pittsburgh on Nov. 28 might stick with the Buckeyes for quite some time. On Dec. 1, the NCAA unveiled the first NCAA Evaluation Tool (NET) rankings for the 2025-26 season. Those ...

Crypto users can trim tax bills by deducting eligible fees, tools, and operating costs, strategically harvesting losses, and using long-term holds and donations to reduce taxable gains, subject to ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The company also recently ...

New Era reported over $4.2 million in losses from operations for the third quarter as it winds down assets toward becoming an integrated power and digital infrastructure company. Image by gunnar3000 ...

AI startup Anthropic is projected to break even by 2028, fueled by steady enterprise client revenue, whereas OpenAI is expected to continue incurring significant operating losses until 2030 due to ...

Bayer BAYN1.63%increase; green up pointing triangle reported a net loss for the third quarter due to litigation charges, though adjusted earnings rose, and said it aims to significantly contain risks ...

Bayer reported a net loss for the third quarter due to litigation charges, though adjusted earnings rose, and said it aims to significantly contain risks from U.S. legal battles by the end of next ...

Anti-obesity drugs would become more available to Medicare enrollees, and drugmakers would reduce the average cost of the meds to about $250 over the next two years, under new deals announced by ...